Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Clinical trial NCT00287092 · COMPLETED

Trial details

NCT number: NCT00287092
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pertussis Diphtheria Tetanus Poliomyelitis Haemophilus Influenzae Type b

Start date: 2006-02-01
Primary completion: 2007-05-01
Enrollment: 807

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.